ARVO 2018: Dr. Steve Rose Reports on CRISPR/Cas9 for Inherited Retinal Diseases

FFB’s own Dr. Steve Rose, chief scientific officer, reviews our commitment to funding and exploring CRISPR/Cas9 gene editing for inherited retinal disease in the video below. FFB currently funds CRISPR/Cas9 projects at four institutions:
  • Johns Hopkins University (retinitis pigmentosa caused by the P23H mutation in RHO)
  • Columbia University (RP caused by the D190N mutation in RHO)
  • Massachusetts Eye and Ear Infirmary (RP caused by a mutation in RP1)
  • UCLA (Usher syndrome 1B caused by a mutation in MYO7A)
Want to learn more about the benefits of CRISPR/Cas9? Check out: A Cut-and-Paste Approach to Fixing Retinal-Disease Genes  

https://www.lvcenter4sight.com/arvo-2018-dr-steve-rose-reports-on-crispr-cas9-for-inherited-retinal-diseases/

Comments

Popular posts from this blog

Overuse of Contact Lenses

Eyelash Extensions – Yay or Nay?

I Spy a Stye in Your Eye